Comparison of 18F-Choline PET/CT and MRI in evaluating initial staging and biochemical relapse of prostate cancer

被引：0
|
作者：
Gaspar, C. J. P. [1 ]
Guerra, A. [2 ]
Dias, A. H. [2 ]
Sousa, V. [2 ]
Loewenthal, C. [2 ]
Vieira, M. R. [2 ]
机构：
[1] Hosp Santa Cruz CHLO, Lisbon, Portugal
[2] Hosp Luz, Lisbon, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP244
引用
收藏
页码：S214 / S214
页数：1
相关论文
共 50 条
  • [31] Role of 18F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer
    Sotirios Chondrogiannis
    Maria Cristina Marzola
    Alice Ferretti
    Anna Margherita Maffione
    Lucia Rampin
    Gaia Grassetto
    Cristina Nanni
    Patrick M. Colletti
    Domenico Rubello
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 1356 - 1364
  • [32] Role of 18F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer
    Chondrogiannis, Sotirios
    Marzola, Maria Cristina
    Ferretti, Alice
    Maffione, Anna Margherita
    Rampin, Lucia
    Grassetto, Gaia
    Nanni, Cristina
    Colletti, Patrick M.
    Rubello, Domenico
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (09) : 1356 - 1364
  • [33] Role of 18F-Choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer
    Marzola, M. C.
    Chondrogiannis, S.
    Ferretti, A.
    Maffione, A. M.
    Rampin, L.
    Grassetto, G.
    Rubello, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S286 - S287
  • [34] Impact of 18F-choline PET-CT on management of patients with biochemical recurrence of prostate cancer
    Teagle, A. R.
    Robinson, A.
    Nikapota, A.
    McKinna, F.
    Dizdarevic, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S673 - S674
  • [35] Pleural Mesothelioma Detects by 18F-Choline PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer
    Marco, Rensi
    Guido, Ferretti
    Fernando, Di Gregorio
    Laura, Evangelista
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (02) : E116 - E117
  • [36] Diagnostic performance of 18F-choline PET-CT in prostate cancer
    P. Samper Ots
    A. Luis Cardo
    C. Vallejo Ocaña
    M. A. Cabeza Rodríguez
    L. A. Glaria Enríquez
    M. L. Couselo Paniagua
    J. Olivera Vegas
    Clinical and Translational Oncology, 2019, 21 : 766 - 773
  • [37] Evaluating the impact of 18F-Choline PET/CT on prostate cancer management: Our retrospective study
    Cardona Arbonies, J.
    Mucientes Rasilla, J.
    Prieto Soriano, A.
    Zapata Paz, I.
    Martinez Ballesteros, C.
    Rodriguez Alfonso, B.
    Mitjavila Casanovas, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S541 - S541
  • [38] Clinical value of 18F-choline PET/CT for biochemical relapse after primary radiation therapy (RT) of prostate cancer (PCA)
    Murat, F. J.
    Poissonnier, L.
    Pasticier, G.
    Mege, F.
    Martin, X.
    Chapelon, J. Y.
    Gelet, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 284 - 284
  • [39] 68Ga-PSMA-PET/CT after a non-contributively 18F-Choline PET/CT in patients in biochemical relapse of prostate cancer
    Skanjeti, Andrea
    Hallouard, Francois
    Dhomps, Anthony
    Darcissac, Caroline
    Morelec, Isabelle
    Got, Philippe
    Deville, Agathe
    Tordo, Jeremie
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [40] 18F-choline PET/CT in prostate cancer biochemical relapse after external beam radiotherapy or brachytherapy: Impact of PSA and kinetics
    Playe, M.
    Cassou-Mounat, T.
    Champion, L.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2020, 44 (01): : 53 - 64
12345